| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 7, Issue 11 1525-1534, Copyright © 1996 by American Association of Cancer Research
ARTICLES |
M Athanasiou, PA Clausen, GJ Mavrothalassitis, XK Zhang, DK Watson and DG Blair
SAIC-Frederick, National Cancer Institute, Frederick Cancer Research and Development Center, Maryland 21702-1201, USA.
The human leukemia cell line K562 can be induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) to differentiate along the megakaryocytic pathway, generating morphological changes and increased expression of lineage-specific surface markers. We report that TPA-treated K562 cells also express higher levels of FLI-1/ERGB, a member of the ETS family of transcription factors. Furthermore, introduction of a retroviral construct expressing human FLI-1/ERGB into K562 cells induces changes similar to those seen following TPA treatment, including increased adherence to the surface of the culture vessel and altered size and morphology. Infected cells exhibit higher levels of the megakaryocyte marker CD41a and, to a lesser extent, CD49b. These markers, as well as virally encoded FLI-1/ERGB-specific RNA and protein, are expressed at the highest levels in the attached cell population, while the growth rate of adherent cells is reduced, and the fraction of cells in G0-G1 is increased. FLI-1/ERGB virus-infected cells also exhibit increased expression of hemoglobin, a marker of erythroid differentiation. Our results suggest FLI-1/ERGB plays a role in controlling differentiation and gene expression along the megakaryocyte/platelet pathway, and further implicate ETS-related genes in the control of multiple developmentally regulated hematopoietic genes.
This article has been cited by other articles:
![]() |
X. K. Zhang, O. Moussa, A. LaRue, S. Bradshaw, I. Molano, D. D. Spyropoulos, G. S. Gilkeson, and D. K. Watson The Transcription Factor Fli-1 Modulates Marginal Zone and Follicular B Cell Development in Mice J. Immunol., August 1, 2008; 181(3): 1644 - 1654. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kaushansky Historical review: megakaryopoiesis and thrombopoiesis Blood, February 1, 2008; 111(3): 981 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pang, H.-H. Xue, G. Szalai, X. Wang, Y. Wang, D. K. Watson, W. J. Leonard, G. A. Blobel, and M. Poncz Maturation stage-specific regulation of megakaryopoiesis by pointed-domain Ets proteins Blood, October 1, 2006; 108(7): 2198 - 2206. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Garzon, F. Pichiorri, T. Palumbo, R. Iuliano, A. Cimmino, R. Aqeilan, S. Volinia, D. Bhatt, H. Alder, G. Marcucci, et al. MicroRNA fingerprints during human megakaryocytopoiesis PNAS, March 28, 2006; 103(13): 5078 - 5083. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Poncz BACH and the megakaryocyte symphony Blood, April 15, 2005; 105(8): 3001 - 3002. [Full Text] [PDF] |
||||
![]() |
X. K. Zhang and D. K. Watson The FLI-1 Transcription Factor Is a Short-Lived Phosphoprotein in T Cells J. Biochem., March 1, 2005; 137(3): 297 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Masuya, O. Moussa, T. Abe, T. Deguchi, T. Higuchi, Y. Ebihara, D. D. Spyropoulos, D. K. Watson, and M. Ogawa Dysregulation of granulocyte, erythrocyte, and NK cell lineages in Fli-1 gene-targeted mice Blood, January 1, 2005; 105(1): 95 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jackers, G. Szalai, O. Moussa, and D. K. Watson Ets-dependent Regulation of Target Gene Expression during Megakaryopoiesis J. Biol. Chem., December 10, 2004; 279(50): 52183 - 52190. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. K. Zhang, S. Gallant, I. Molano, O. M. Moussa, P. Ruiz, D. D. Spyropoulos, D. K. Watson, and G. Gilkeson Decreased Expression of the Ets Family Transcription Factor Fli-1 Markedly Prolongs Survival and Significantly Reduces Renal Disease in MRL/lpr Mice J. Immunol., November 15, 2004; 173(10): 6481 - 6489. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Sevinsky, A. M. Whalen, and N. G. Ahn Extracellular Signal-Regulated Kinase Induces the Megakaryocyte GPIIb/CD41 Gene through MafB/Kreisler Mol. Cell. Biol., May 15, 2004; 24(10): 4534 - 4545. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Eisbacher, M. L. Holmes, A. Newton, P. J. Hogg, L. M. Khachigian, M. Crossley, and B. H. Chong Protein-Protein Interaction between Fli-1 and GATA-1 Mediates Synergistic Expression of Megakaryocyte-Specific Genes through Cooperative DNA Binding Mol. Cell. Biol., May 15, 2003; 23(10): 3427 - 3441. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Starck, N. Cohet, C. Gonnet, S. Sarrazin, Z. Doubeikovskaia, A. Doubeikovski, A. Verger, M. Duterque-Coquillaud, and F. Morle Functional Cross-Antagonism between Transcription Factors FLI-1 and EKLF Mol. Cell. Biol., February 15, 2003; 23(4): 1390 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Hodge, W. Xiao, P. A. Clausen, G. Heidecker, M. Szyf, and W. L. Farrar Interleukin-6 Regulation of the Human DNA Methyltransferase (HDNMT) Gene in Human Erythroleukemia Cells J. Biol. Chem., October 19, 2001; 276(43): 39508 - 39511. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Shivdasani Molecular and Transcriptional Regulation of Megakaryocyte Differentiation Stem Cells, September 1, 2001; 19(5): 397 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Eisbacher, L. M. Khachigian, T. H. Khin, M. L. Holmes, and B. H. Chong Inducible Expression of the Megakarocyte-specific Gene Glycoprotein IX Is Mediated through an Ets Binding Site and Involves Upstream Activation of Extracellular Signal-regulated Kinase Cell Growth Differ., August 1, 2001; 12(8): 435 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Spyropoulos, P. N. Pharr, K. R. Lavenburg, P. Jackers, T. S. Papas, M. Ogawa, and D. K. Watson Hemorrhage, Impaired Hematopoiesis, and Lethality in Mouse Embryos Carrying a Targeted Disruption of the Fli1 Transcription Factor Mol. Cell. Biol., August 1, 2000; 20(15): 5643 - 5652. [Abstract] [Full Text] |
||||
![]() |
T. Era, T. Takagi, T. Takahashi, J.-C. Bories, and T. Nakano Characterization of hematopoietic lineage-specific gene expression by ES cell in vitro differentiation induction system Blood, February 1, 2000; 95(3): 870 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lepage, G. Uzan, N. Touche, M. Morales, J.-P. Cazenave, F. Lanza, and C. de la Salle Functional Characterization of the Human Platelet Glycoprotein V Gene Promoter: A Specific Marker of Late Megakaryocytic Differentiation Blood, November 15, 1999; 94(10): 3366 - 3380. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Bastian, B. A. Kwiatkowski, J. Breininger, S. Danner, and G. Roth Regulation of the Megakaryocytic Glycoprotein IX Promoter by the Oncogenic Ets Transcription Factor Fli-1 Blood, April 15, 1999; 93(8): 2637 - 2644. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Maulon, S. Guérin, J. E. Ricci, Y. Colin, J. P. Cartron, and P. Auberger Differential expression of the Kell blood group and CD10 antigens: two related membrane metallopeptidases during differentiation of K562 cells by phorbol ester and hemin FASEB J, May 1, 1998; 12(7): 531 - 539. [Abstract] [Full Text] |
||||
![]() |
A. Doubeikovski, G. Uzan, Z. Doubeikovski, M.-H. Prandini, F. Porteu, S. Gisselbrecht, and I. Dusanter-Fourt Thrombopoietin-induced Expression of the Glycoprotein IIb Gene Involves the Transcription Factor PU.1/Spi-1 in UT7-Mpl Cells J. Biol. Chem., September 26, 1997; 272(39): 24300 - 24307. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Lam, C. Ronchini, J. Norton, A. J. Capobianco, and E. H. Bresnick Suppression of Erythroid but Not Megakaryocytic Differentiation of Human K562 Erythroleukemic Cells by Notch-1 J. Biol. Chem., June 23, 2000; 275(26): 19676 - 19684. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |